Moderators

James M. Downey, PhD
Professor
Department of Physiology
University of South Alabama
Mobile, AL
Email: jdowney@usouthal.edu


Masatsugu Hori, MD, PhD
Professor and Chairman
Department of Cardiovascular Medicine
Osaka University Graduate School of Medicine
Osaka, Japan
Email: mhori@medone.med.osaka-u.ac.jp


Masafumi Kitakaze, MD, PhD
Director, Cardiovascular Division
Vice President, Clinical Research Center
National Cardiovascular Center
Osaka, Japan
Email: kitakaze@zf6.so-net.jp


Robert M. Mentzer, Jr., MD
Dean, School of Medicine
Senior Advisor to the President for Medical Affairs
Professor, Physiology and Surgery
Wayne State University
Detroit, MI
e-mail: rmentzer@med.wayne.edu

Invited Speakers

Michel Ovize, MD, PhD
Hôpital Cardiologique and Pneumologique Louis Pradel
Lyon, France
Email: michel.ovize@recherche.univ-lyon1.fr
Clinical Experience with Postconditioning. Is it Ready For Prime Time?

Kevin Grimes, MD
KAI Pharmaceuticals
South San Francisco, CA
Email: kevin.grimes@kaipharma.com
δ-PKC Inhibition in Primary PCI: An Exploratory Trial

Robert M. Mentzer, Jr., MD
Dean, School of Medicine
Senior Advisor to the President for Medical Affairs
Professor, Physiology and Surgery
Wayne State University
Detroit, MI
e-mail: rmentzer@med.wayne.edu
BNP in CABG Patients with Heart Failure

Derek Hausenloy,  MD, PhD
University College, London
Email: d.hausenloy@ucl.ac.uk
Remote Preconditioning: a New Clinical Entity? 

Robert A. Kloner, MD, PhD
University of Southern California, Los Angeles
Email: rkloner@goodsam.org
Sub-Group Analysis of the AMISTAD 2 Adenosine Trial.  Was it Really Negative?

Masanori Asakura, MD, PhD
National Cardiovascular Center, Osaka
Email: asamasa@xd5.so-net.ne.jp
J-WIND: a Multicenter Study of ANP and Nicorandil in PCI

Christopher B. Granger, MD
Duke University, Durham
Email: christopher.granger@duke.edu
Why Has it Been so Difficult to Identify a Cardioprotectant for Acute MI?